U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C12H11N5O
Molecular Weight 241.2486
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of PELDESINE

SMILES

NC1=NC2=C(NC=C2CC3=CN=CC=C3)C(=O)N1

InChI

InChIKey=DOHVAKFYAHLCJP-UHFFFAOYSA-N
InChI=1S/C12H11N5O/c13-12-16-9-8(4-7-2-1-3-14-5-7)6-15-10(9)11(18)17-12/h1-3,5-6,15H,4H2,(H3,13,16,17,18)

HIDE SMILES / InChI
Peldesine (also known as BCX-34) was developed as a purine nucleoside phosphorylase (PNP) inhibitor. It is known PNP inhibitors may be useful for treating a variety of T-cell related autoimmune diseases including psoriasis, rheumatoid arthritis, and Crohn s disease and T-cell cancers. Peldesine has undergone phase I trials for the treatment of human Immunodeficiency virus (HIV) infections. In addition, this drug participated in phase III clinical trial as a topical therapy for cutaneous T-cell lymphoma. This drug was also studied as a potential therapy for psoriasis, multiple sclerosis; rheumatoid arthritis; transplant rejection. However, all these indications were discontinued because of the lack of significant effects over placebo.

Approval Year

PubMed

PubMed

TitleDatePubMed
A phase III, randomized, double-blind, placebo-controlled study of peldesine (BCX-34) cream as topical therapy for cutaneous T-cell lymphoma.
2001 Jun
Biological activity of inorganic arsenic and antimony reflects oxidation state in cultured human keratinocytes.
2003 Dec
Case study: institutional review board (IRB) did not know about subject problem until after study.
2006 May
Patents

Sample Use Guides

peldesine (BCX-34) in a 1% dermal cream formulation. BCX-34 dermal cream 1% or the vehicle cream (as a placebo control) was applied twice daily to the entire skin surface for up to 24 weeks.
Route of Administration: Topical
Name Type Language
PELDESINE
INN   MART.   USAN  
INN   USAN  
Official Name English
4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE, 2-AMINO-3,5-DIHYDRO-7-(3-PYRIDINYLMETHYL)-
Systematic Name English
Peldesine [WHO-DD]
Common Name English
2-Amino-3,5-dihydro-7-(3-pyridylmethyl)-4H-pyrrolo[3,2-d]pyrimidin-4-one
Systematic Name English
BCX-34
Code English
PELDESINE [USAN]
Common Name English
peldesine [INN]
Common Name English
PELDESINE [MART.]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C2151
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
FDA ORPHAN DRUG 76293
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
Code System Code Type Description
INN
7405
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
USAN
GG-27
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
EPA CompTox
DTXSID10158107
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
ChEMBL
CHEMBL311300
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
NCI_THESAURUS
C1650
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
PUBCHEM
135413525
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
CAS
133432-71-0
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
MESH
C104194
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
DRUG BANK
DB02568
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
FDA UNII
7B646RJ70F
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
EVMPD
SUB09649MIG
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY
SMS_ID
100000083007
Created by admin on Sat Dec 16 06:14:35 GMT 2023 , Edited by admin on Sat Dec 16 06:14:35 GMT 2023
PRIMARY